Hemostemix Statistics

Total Valuation

Hemostemix has a market cap or net worth of CAD 17.49 million. The enterprise value is 22.20 million.

Market Cap	17.49M
Enterprise Value	22.20M

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Hemostemix has 145.73 million shares outstanding. The number of shares has increased by 11.69% in one year.

Current Share Class	n/a
Shares Outstanding	145.73M
Shares Change (YoY)	+11.69%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.79%
Owned by Institutions (%)	n/a
Float	116.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-11.14
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-207.04%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	41.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.00% in the last 52 weeks. The beta is 0.46, so Hemostemix's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+60.00%
50-Day Moving Average	0.22
200-Day Moving Average	0.11
Relative Strength Index (RSI)	34.53
Average Volume (20 Days)	1,170,503

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.42M
Pretax Income	-1.99M
Net Income	-1.99M
EBITDA	-1.42M
EBIT	-1.42M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 63,327 in cash and 4.77 million in debt, giving a net cash position of -4.71 million or -0.03 per share.

Cash & Cash Equivalents	63,327
Total Debt	4.77M
Net Cash	-4.71M
Net Cash Per Share	-0.03
Equity (Book Value)	-8.67M
Book Value Per Share	-0.10
Working Capital	-3.41M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-332,574
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Hemostemix does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.69%
Shareholder Yield	-11.69%
Earnings Yield	-11.40%
FCF Yield	n/a

Stock Splits

The last stock split was on December 30, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Dec 30, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a